Enbrel vs Skyrizi — Comparison & Availability

EnbrelSkyrizi
Brand NameEnbrelSkyrizi
Generic Nameetanerceptrisankizumab
Drug ClassTNF inhibitorIL-23 inhibitor
Findability Score66/10066/100
FindabilityModerateModerate
Avg Pharmacy Calls~10~10

Which Is Easier to Find Right Now?

Both Enbrel and Skyrizi have similar findability scores of 66/100. You may need to call around 10 pharmacies to locate either one. Let FindUrMeds do the searching for you.

Key Differences Between Enbrel and Skyrizi

Enbrel (etanercept) is a TNF inhibitor, while Skyrizi (risankizumab) is a IL-23 inhibitor. These different drug classes mean they work through distinct mechanisms in the body, which can affect efficacy, side effects, and suitability for different patients.

Because they belong to different classes, switching between Enbrel and Skyrizi is a decision that should be made carefully with your healthcare provider, who can weigh the benefits and risks for your particular situation.

Frequently Asked Questions

Is Enbrel or Skyrizi easier to find?

Based on current availability data, Enbrel has a Findability Score of 66/100 compared to Skyrizi's 66/100. Enbrel typically requires about 10 pharmacy calls to locate, while Skyrizi may take around 10 calls.

Can I switch from Enbrel to Skyrizi?

Switching between Enbrel and Skyrizi requires a conversation with your prescribing doctor. They can evaluate whether the switch is appropriate based on your medical history, current condition, and how you've responded to your current medication. Never switch medications without medical guidance.

Which is cheaper, Enbrel or Skyrizi?

Prices vary by pharmacy, insurance coverage, and whether a generic is available. Enbrel (generic: etanercept) and Skyrizi (generic: risankizumab) may have different out-of-pocket costs depending on your plan. Using GoodRx coupons or asking your pharmacist about generic alternatives can help reduce costs for either medication.

Summarize this article with AI:

Learn More